Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: File photo shows a young carer holding the hands of an elderly woman in a residential home for the elderly in Planegg near Munich June 19, 2007. REUTERS/Michaela Rehle The study, reported on Sunday in the journal BioMed Central BMC Neurology, involved 12 patients who had greatly improved language recall shortly after treatment with Enbrel, or etanercept, an anti-inflammatory drug co-marketed by Amgen and Wyeth. "We often see verbal effects within a few minutes of the first dose," said Dr. Edward Tobinick, director of the Institute for Neurological Research, a private medical group inc., in Los Angeles, who led the study. Tobinick invented and holds several patents on a special method of injecting the drug into the neck. He said he charges anywhere between $10,000 and $40,000 per patient for the treatments. In January, Tobinick's report on a single patient, and release of a striking video, drew the attention of the Alzheimer's Association, which released a statement expressing concern. "People with Alzheimer's and their families may place undue value on this new finding based on the dramatic language used in its description and the apparent immediate effect," the group said. "We need to see work in other laboratories by scientists without financial interest in the product," it added. Dr. Sam Gandy, chairman of the Alzheimer's Association's medical and science council, said the latest study, done at Tobinick's clinic, does not offer that independent confirmation. "It's still not a proper trial," Gandy said. Tobinick believes the drug may work in the brain by blocking an excess of tumor necrosis factor-alpha or TNF-alpha, which may affect communication in the brain. The study looked at language difficulties, such as in finding words, in 12 patients with mild-to-severe Alzheimer's disease who were administered etanercept weekly for six months. "There was a significant improvement in the majority of the verbal measures that were studied. The remainder showed a tendency toward improvement, which was not significant," Tobinick said in a telephone interview. He said the study provides evidence that "excess TNF, in the Alzheimer brain, may offer a new way to address this language dysfunction." Tobinick acknowledged the study is limited because people knew they were getting the drug. Alzheimer's patients in such open-label studies often show improvement. "Placebo effect is an enormous problem in open-label studies," said Dr. Scott Turner, incoming director of the Memory Disorders Program at Georgetown University Medical Center in Washington. Turner said the true test must come from a more scientifically rigorous double-blind, placebo-controlled, randomized clinical trial. In such studies, patients receive either a dummy treatment or an active agent, and neither the doctor nor the patient knows which. Amgen has also expressed concern about the research, claiming there has been insufficient evidence so far. "This off-label, unapproved treatment, administered by Dr. Edward Tobinick, is not supported nor endorsed by Amgen," the company said in April on its Web site. A video showing one woman's response to the drug in a sister study can be found at : here
[EX A]: Drug restores speech in Alzheimer's; experts worry.

[EX Q]: While the story does describe the cost of stenting, it does not provide the cost of the medication for comparison. The story does give the rate of heart attack or death as 19% within 7 years for both the stent and the medication group. Although the study mentions the risk of clotting with drug-coated stents, this is not adequate information on harms. Furthermore, the study does not mention any possible harms of medication. The story adequately describes the design of the current study. The story does not exaggerate the seriousness or prevalence of heart disease. Furthermore, the story clearly states that this study was done on patients at low risk, that is, those with stable heart disease. The story only quotes one cardiologist not associated with the study and gives no rationale for why he was chosen. (Is it because he's in New York and readily available?) The story could have quoted other clinicians or experts who could have provided some valuable perspective on the impact of this new development on the management of heart disease. The story does mention medication as the alternative to stenting. The story clearly states that stenting is very common in the U.S. The story clearly states that stenting is not a new idea. Because the story quotes the lead author of the study and one physician who is not related to the study, the reader can assume the story did not rely on a press release as the sole source of information.
[EX A]: Heart study: Most angioplasties not needed

[EX Q]: Save the Children said in a report released Tuesday saying that U.N. statistics show at least 280 million children are better off today. But it said a quarter of the world's children are still denied the right to a safe and healthy childhood, with youngsters fleeing or caught in conflict the most disadvantaged. Singapore tops the rankings as the country that best protects and provides for its children, followed by Sweden, Finland, Norway, Slovenia, Germany, Ireland, Italy, South Korea and Belgium. At the bottom were Central African Republic, Niger despite recent progress, Chad, Mali and South Sudan. The Global Childhood Report 2019 said the most dramatic progress since 2000 was among some of the world's poorest countries. Sierra Leone made the biggest improvements, followed by Rwanda, Ethiopia and Niger. The United States ranks 36th in the 2019 report, tied with China. It ranks just above Bahrain, Belarus and Kuwait and ahead of Bosnia and Russia, tied at 38. Carolyn Miles, president and CEO of Save the Children, said the report looked at eight indicators of a good childhood including child survival, education, child labor and early marriage and compared the year 2000 with 2018. "There has been remarkable progress if you look across the world," she said at a recent briefing on the report's finding. "It's an amazing statistic" that the indicators overall got better in 173 of 176 countries. Compared with 2000, Miles said there was a 49% drop in deaths of children under age 5, a 40% drop in child labor, a 33% drop in chronic malnutrition and stunting, and a 25% drop in child marriage. She said only one of the indicators rose the number of children living in conflict or affected by violence and it increased "very significantly." There was an 80% rise in children living in or fleeing conflict zones in the 2000-2018 period, Miles said, "and today's conflicts last much, much longer." According to the report, an estimated 420 million children are living in conflict zones, more than double the number in 1995, and nearly 31 million children today have been forcibly displaced from their homes. Launched ahead of International Children's Day on June 1, the report said that in 2000, an estimated 970 million children were robbed of their childhood by events such as exclusion from education, malnutrition, sickness, violent death, child marriage and early pregnancy. That number today has been reduced to 690 million, it said, meaning at least 280 million children are better off today than they would have been in 2000. The report said this means that today there are 4.4 million fewer child deaths every year, 49 million fewer stunted children, 130 million more children in school, 94 million fewer children working, 11 million fewer child marriages and 3 million fewer teen births.
[EX A]:
Child advocacy group: Kids in 173 countries better off now.